For Employers
Metabolic health solutions for your people
Our metabolic health benefit combines AI digital twin™ technology with clinical care to address the root cause of type 2 diabetes, obesity, prediabetes, and much more.
Trusted by leading companies
.avif)
The power of a healthy metabolism
Our outcomes aren’t just clinical — they’re human. With better metabolic health, members wake up with more energy, play with their kids or grandkids a little longer, and enjoy a weekend getaway without packing their meds.
71%
lowered A1C below 6.5% without glucose-lowering medications (except metformin)
-27 lbs
average weight loss
85%
GLP-1 elimination
46%
insulin elimination
*2025 Twin Health group results of the Cleveland Clinic study published in the New England Journal of Medicine Catalyst. Individual results may vary.
The weight loss GLP-1 model that aligns lasting health with lower costs
The key to healing chronic conditions
Metabolic issues like inflammation and insulin resistance are behind many chronic health conditions. By working with a member’s unique metabolism, Twin Health’s programs address and improve many of the symptoms of metabolic conditions:
Hypertension
Inflammation
Insomnia
Fatigue
Chronic aches & pains
Immune function
Insulin resistance
Reliance on medications
Visceral fat
What our clients are saying
The highlight for us has been the flexibility....but more importantly the clinical integrity of your product and services.
Chief Clinical Officer at Leading Global Investment Firm
Twin has been excellent to work with to deliver cost-effective solutions.
Sr. Benefits Leader at Diversified Holdings Company
Independently validated by Duke-Margolis
Twin members continue to lose weight after stopping GLP-1s
1. Based on the semaglutide (Ozempic) clinical trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/#dom14725-supitem-0001) N=228
2. Inclusive of Active Commercial Members >=52 weeks in the Twin T2D Program who stopped GLP-1 >=52 weeks prior to the analysis and had a start BMI >=27
Twin members continue losing weight after stopping GLP-1s
Twin members2
continue to lose ~6% of body weight on average
Patients without Twin
gain back ~13%
1. Based on the semaglutide (Ozempic) clinical trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/#dom14725-supitem-0001) N=228
2. Inclusive of Active Commercial Members >=52 weeks in the Twin T2D Program who stopped GLP-1 >=52 weeks prior to the analysis and had a start BMI >=27
Validated by clinical research
We stand behind our solutions
We’re so confident in the efficacy of our programs that our metabolic health benefits are offered fully at-risk. These programs are based upon the highest quality RCT research, which has been peer-reviewed and published in leading journals.
*Outcomes from a Twin self-insured employer partner
19%
Eligible population activated
within the first year
$8.0k
Annualized savings per member
with at least one high-cost medication
$3.2M
Projected pharmacy savings
annualized across all members with 1 or more high-cost meds*
As featured in
%20(1)%201.png){kind=logo}
Recognized by the Validation Institute
Endorsed for Clinical Outcomes and Contractual Validity, Twin Health’s transparent, results-based model ensures employers and health plans pay only for outcomes proven to improve health and reduce costs.
Drive health outcomes & ROI
Learn how Twin Health partners with employers and health plans to deliver clinically proven, all-fees-at-risk programs that improve member health while reducing costs.
